TONIX PHARMACEUTICALS HOLDING CORP. Financing Cash Flow
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) reported Financing Cash Flow of $53.71 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-10
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $33.51M, a 204.78% increase year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $20.20M, a 59.21% decline year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $59.14M, a 30.55% decline year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $94.86M, a 121.10% increase year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) financing activities for fiscal 2025 was $214.53M, a 59.06% increase from fiscal 2024.
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) financing activities for fiscal 2024 was $134.87M, a 269.34% increase from fiscal 2023.
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) financing activities for fiscal 2023 was $36.52M, a 58.43% decline from fiscal 2022.
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) financing activities for fiscal 2022 was $87.84M, a 58.66% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 43 month | Net Cash Provided by (Used in) Financing Activities 46 month | Net Cash Provided by (Used in) Financing Activities 55 month | Net Cash Provided by (Used in) Financing Activities 58 month | Net Cash Provided by (Used in) Financing Activities 61 month | Net Cash Provided by (Used in) Financing Activities 64 month | Net Cash Provided by (Used in) Financing Activities 67 month | Net Cash Provided by (Used in) Financing Activities 70 month | Net Cash Provided by (Used in) Financing Activities 73 month | Net Cash Provided by (Used in) Financing Activities 76 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $33.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $53.71M 10-Q · filed 2026-08-10 | $112.85M derived: sum of 3 quarters · filed 2026-08-10 | $207.71M derived: sum of 4 quarters · filed 2026-08-10 | |||||||||||||
| 2026-03-31 | $20.20M 10-Q · filed 2026-05-11 | $79.35M derived: sum of 2 quarters · filed 2026-05-11 | $174.21M derived: sum of 3 quarters · filed 2026-05-11 | $185.20M derived: sum of 4 quarters · filed 2026-08-10 | |||||||||||||
| 2025-12-31 | $59.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $154.00M derived: sum of 2 quarters · filed 2026-03-12 | $165.00M derived: sum of 3 quarters · filed 2026-08-10 | $214.53M 10-K · filed 2026-03-12 | |||||||||||||
| 2025-09-30 | $94.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $105.85M derived: sum of 2 quarters · filed 2026-08-10 | $155.39M 10-Q · filed 2025-11-10 | $240.54M derived: sum of 4 quarters · filed 2026-08-10 | |||||||||||||
| 2025-06-30 | $10.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $60.53M 10-Q · filed 2026-08-10 | $145.68M derived: sum of 3 quarters · filed 2026-08-10 | $188.59M derived: sum of 4 quarters · filed 2026-08-10 | |||||||||||||
| 2025-03-31 | $49.53M 10-Q · filed 2026-05-11 | $134.69M derived: sum of 2 quarters · filed 2026-05-11 | $177.59M derived: sum of 3 quarters · filed 2026-05-11 | $184.62M derived: sum of 4 quarters · filed 2026-05-11 | |||||||||||||
| 2024-12-31 | $85.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $128.06M derived: sum of 2 quarters · filed 2026-03-12 | $135.08M derived: sum of 3 quarters · filed 2026-03-12 | $134.87M 10-K · filed 2026-03-12 | |||||||||||||
| 2024-09-30 | $42.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $49.93M derived: sum of 2 quarters · filed 2025-11-10 | $49.72M 10-Q · filed 2025-11-10 | $90.43M derived: sum of 4 quarters · filed 2025-11-10 | |||||||||||||
| 2024-06-30 | $7.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $6.81M 10-Q · filed 2025-08-11 | $47.53M derived: sum of 3 quarters · filed 2025-08-11 | $53.80M derived: sum of 4 quarters · filed 2025-08-11 | |||||||||||||
| 2024-03-31 | -$212.00K 10-Q · filed 2025-05-12 | $40.50M derived: sum of 2 quarters · filed 2025-05-12 | $46.78M derived: sum of 3 quarters · filed 2025-05-12 | $47.80M derived: sum of 4 quarters · filed 2025-05-12 | |||||||||||||
| 2023-12-31 | $40.71M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $46.99M derived: sum of 2 quarters · filed 2025-03-18 | $48.02M derived: sum of 3 quarters · filed 2025-03-18 | $36.52M 10-K · filed 2025-03-18 | |||||||||||||
| 2023-09-30 | $6.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $7.30M derived: sum of 2 quarters · filed 2024-11-12 | -$4.20M 10-Q · filed 2024-11-12 | $3.03M derived: sum of 4 quarters · filed 2024-11-12 | |||||||||||||
| 2023-06-30 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-16 | -$10.47M 10-Q · filed 2024-08-16 | -$3.24M derived: sum of 3 quarters · filed 2024-08-16 | -$7.87M derived: sum of 4 quarters · filed 2024-08-16 | |||||||||||||
| 2023-03-31 | -$11.50M 10-Q · filed 2024-05-13 | -$4.27M derived: sum of 2 quarters · filed 2024-05-13 | -$8.90M derived: sum of 3 quarters · filed 2024-05-13 | $63.28M derived: sum of 4 quarters · filed 2024-05-13 | |||||||||||||
| 2022-12-31 | $7.23M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $2.60M derived: sum of 2 quarters · filed 2024-04-01 | $74.78M derived: sum of 3 quarters · filed 2024-04-01 | $87.84M 10-K · filed 2024-04-01 | |||||||||||||
| 2022-09-30 | -$4.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $67.55M derived: sum of 2 quarters · filed 2023-11-09 | $80.61M 10-Q · filed 2023-11-09 | $124.38M derived: sum of 4 quarters · filed 2023-11-09 | |||||||||||||
| 2022-06-30 | $72.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $85.24M 10-Q · filed 2023-08-10 | $129.01M derived: sum of 3 quarters · filed 2023-08-10 | $166.97M derived: sum of 4 quarters · filed 2023-08-10 | |||||||||||||
| 2022-03-31 | $13.06M 10-Q · filed 2023-05-08 | $56.83M derived: sum of 2 quarters · filed 2023-05-08 | $94.79M derived: sum of 3 quarters · filed 2023-05-08 | $116.84M derived: sum of 4 quarters · filed 2023-05-08 | |||||||||||||
| 2021-12-31 | $43.77M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $81.73M derived: sum of 2 quarters · filed 2023-03-13 | $103.78M derived: sum of 3 quarters · filed 2023-03-13 | $212.49M 10-K · filed 2023-03-13 | |||||||||||||
| 2021-09-30 | $37.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $60.01M derived: sum of 2 quarters · filed 2022-11-07 | $168.72M 10-Q · filed 2022-11-07 | $208.58M derived: sum of 4 quarters · filed 2022-11-07 | |||||||||||||
| 2021-06-30 | $22.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $130.76M 10-Q · filed 2022-08-08 | $170.62M derived: sum of 3 quarters · filed 2022-08-08 | $190.69M derived: sum of 4 quarters · filed 2022-08-08 | |||||||||||||
| 2021-03-31 | $108.71M 10-Q · filed 2022-05-09 | $148.57M derived: sum of 2 quarters · filed 2022-05-09 | $168.64M derived: sum of 3 quarters · filed 2022-05-09 | $203.06M derived: sum of 4 quarters · filed 2022-05-09 | |||||||||||||
| 2020-12-31 | $39.86M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $59.93M derived: sum of 2 quarters · filed 2022-03-14 | $94.35M derived: sum of 3 quarters · filed 2022-03-14 | $123.11M 10-K · filed 2022-03-14 | |||||||||||||
| 2020-09-30 | $20.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $54.49M derived: sum of 2 quarters · filed 2021-11-08 | $83.25M 10-Q · filed 2021-11-08 | $91.16M derived: sum of 4 quarters · filed 2021-11-08 | |||||||||||||
| 2020-06-30 | $34.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $63.18M 10-Q · filed 2021-08-09 | $71.09M derived: sum of 3 quarters · filed 2021-08-09 | $75.61M derived: sum of 4 quarters · filed 2021-08-09 | |||||||||||||
| 2020-03-31 | $28.76M 10-Q · filed 2021-05-10 | $36.67M derived: sum of 2 quarters · filed 2021-05-10 | $41.19M derived: sum of 3 quarters · filed 2021-05-10 | $41.60M derived: sum of 4 quarters · filed 2021-05-10 | |||||||||||||
| 2019-12-31 | $7.91M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $12.43M derived: sum of 2 quarters · filed 2021-03-15 | $12.85M derived: sum of 3 quarters · filed 2021-03-15 | $12.92M 10-K · filed 2021-03-15 | |||||||||||||
| 2019-09-30 | $4.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $4.93M derived: sum of 2 quarters · filed 2020-11-09 | $5.00M 10-Q · filed 2020-11-09 | $4.97M 10-Q · filed 2019-11-08 | $22.19M derived: sum of 4 quarters · filed 2020-11-09 | ||||||||||||
| 2019-06-30 | $417.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $490.00K 10-Q · filed 2020-08-10 | $17.68M derived: sum of 3 quarters · filed 2020-08-10 | $20.57M derived: sum of 4 quarters · filed 2020-08-10 | |||||||||||||
| 2019-03-31 | $73.00K 10-Q · filed 2020-05-12 | $70.00K 10-Q · filed 2019-05-13 | $17.26M derived: sum of 2 quarters · filed 2020-05-12 | $20.15M derived: sum of 3 quarters · filed 2020-05-12 | $23.08M derived: sum of 4 quarters · filed 2020-05-12 | ||||||||||||
| 2018-12-31 | $17.19M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-24 | $20.08M derived: sum of 2 quarters · filed 2020-03-24 | $23.01M derived: sum of 3 quarters · filed 2020-03-24 | $23.54M 10-K · filed 2020-03-24 | |||||||||||||
| 2018-09-30 | $2.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $5.82M derived: sum of 2 quarters · filed 2019-11-08 | $6.35M 10-Q · filed 2019-11-08 | $7.47M derived: sum of 4 quarters · filed 2019-11-08 | |||||||||||||
| 2018-06-30 | $2.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $3.46M 10-Q · filed 2019-08-12 | $4.58M derived: sum of 3 quarters · filed 2019-08-12 | $4.58M derived: sum of 4 quarters · filed 2019-08-12 | |||||||||||||
| 2018-03-31 | $532.00K 10-Q · filed 2019-05-13 | $1.65M derived: sum of 2 quarters · filed 2019-05-13 | $1.65M derived: sum of 3 quarters · filed 2019-05-13 | $17.95M derived: sum of 4 quarters · filed 2019-05-13 | |||||||||||||
| 2017-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $1.12M derived: sum of 2 quarters · filed 2019-03-18 | $17.42M derived: sum of 3 quarters · filed 2019-03-18 | $18.52M 10-K · filed 2019-03-18 | |||||||||||||
| 2017-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $16.30M derived: sum of 2 quarters · filed 2018-11-09 | $17.40M 10-Q · filed 2018-11-09 | $22.26M derived: sum of 4 quarters · filed 2018-11-09 | |||||||||||||
| 2017-06-30 | $16.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $17.40M 10-Q · filed 2018-08-13 | $22.26M derived: sum of 3 quarters · filed 2018-08-13 | ||||||||||||||
| 2017-03-31 | $1.10M 10-Q · filed 2018-05-11 | $5.96M derived: sum of 2 quarters · filed 2018-05-11 | |||||||||||||||
| 2016-12-31 | $4.86M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $20.50M 10-K · filed 2018-03-09 | |||||||||||||||
| 2016-09-30 | $15.64M 10-Q · filed 2017-11-06 | ||||||||||||||||
| 2013-09-30 | $10.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $10.63M derived: sum of 2 quarters · filed 2013-11-13 | $10.63M 10-Q · filed 2013-11-13 | $13.88M derived: sum of 4 quarters · filed 2013-11-22 | $22.76M 10-Q · filed 2013-11-13 | ||||||||||||
| 2013-06-30 | $405.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $405.75K 10-Q · filed 2013-08-14 | $3.66M derived: sum of 3 quarters · filed 2013-11-22 | $3.66M derived: sum of 4 quarters · filed 2013-11-22 | $12.53M 10-Q · filed 2013-08-14 | ||||||||||||
| 2013-03-31 | $0.00 10-Q · filed 2013-05-07 | $3.25M derived: sum of 2 quarters · filed 2013-11-22 | $3.25M derived: sum of 3 quarters · filed 2013-11-22 | $3.25M derived: sum of 4 quarters · filed 2013-11-22 | $12.13M 10-Q · filed 2013-05-07 | ||||||||||||
| 2012-12-31 | $3.25M derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-11-22 | $3.25M derived: sum of 2 quarters · filed 2013-11-22 | $3.25M derived: sum of 3 quarters · filed 2013-11-22 | $7.49M 10-K/A · filed 2013-11-22 | $12.13M 10-K/A · filed 2013-11-22 | ||||||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$1.00 derived: sum of 2 quarters · filed 2013-11-13 | $4.24M 10-Q · filed 2013-11-13 | $5.74M derived: sum of 4 quarters · filed 2013-11-22 | $8.87M 10-Q · filed 2012-11-14 | ||||||||||||
| 2012-06-30 | -$1.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $4.24M 10-Q · filed 2013-08-14 | $5.74M derived: sum of 3 quarters · filed 2013-11-22 | $6.28M derived: sum of 4 quarters · filed 2013-11-22 | $8.87M 10-Q · filed 2012-08-13 | ||||||||||||
| 2012-03-31 | $4.24M 10-Q · filed 2013-05-07 | $5.74M derived: sum of 2 quarters · filed 2013-11-22 | $6.28M derived: sum of 3 quarters · filed 2013-11-22 | $6.55M derived: sum of 4 quarters · filed 2013-11-22 | $8.87M 10-Q · filed 2012-05-15 | ||||||||||||
| 2011-12-31 | $1.50M derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-11-22 | $2.04M derived: sum of 2 quarters · filed 2013-11-22 | $2.31M derived: sum of 3 quarters · filed 2013-11-22 | $2.61M 10-K/A · filed 2013-11-22 | $4.64M 10-K · filed 2012-03-30 | ||||||||||||
| 2011-09-30 | $544.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $809.00K derived: sum of 2 quarters · filed 2012-11-14 | $1.11M 10-Q · filed 2012-11-14 | $0.00 10-Q · filed 2011-10-07 | $2.50M derived: sum of 4 quarters · filed 2012-11-14 | $75.00K 10-Q · filed 2011-10-07 | |||||||||||
| 2011-06-30 | $265.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | $568.00K 10-Q · filed 2012-08-13 | $0.00 10-Q · filed 2011-08-15 | $1.96M derived: sum of 3 quarters · filed 2012-08-13 | $1.96M derived: sum of 4 quarters · filed 2012-08-13 | $75.00K 10-Q · filed 2011-08-15 | |||||||||||
| 2011-03-31 | $303.00K 10-Q · filed 2012-05-15 | $1.69M derived: sum of 2 quarters · filed 2012-05-15 | $1.70M derived: sum of 3 quarters · filed 2012-05-15 | ||||||||||||||
| 2010-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $1.39M derived: sum of 2 quarters · filed 2012-03-30 | $1.39M 10-K · filed 2012-03-30 | ||||||||||||||
| 2010-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-07 | $2.00K 10-Q · filed 2011-10-07 | |||||||||||||||
| 2010-06-30 | $0.00 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |